HEALTH● LOWAug 13 · Aug 13, 2026, 9:29 PM
Bristol gains accelerated approval of iberdomide for multiple myeloma
Seeking Alpha Tech
Bristol has received accelerated approval for iberdomide, a drug intended for the treatment of multiple myeloma. This development expands treatment options for patients with the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH40m agoUganda says it has no active Ebola cases, but infections in Kenya and Nigeria are prompting fresh scrutinyDW News [en]HEALTH49m agoAfrica CDC probes possible link between Ebola cases in Nigeria, KenyaPremium TimesHEALTH50m agoRobert Waldinger, Harvard psychiatrist expert in longevity and well-being: "People in their 80s reflected on their lives, they were asked what they were most proud of, it was never an award won or money accumulated, but their connections with other people"ClarínHEALTH59m agoEbola: Nigerian govt urges 15 states to speed up preparednessPremium Times